Esmo 2022 – Galleri’s real-world exhibition disappoints

Full data from a study assessing real-world use of a version of Grail’s – or is it Illumina’s? – multi-cancer screening test has revealed respectable predictive values. But not as respectable as they used to be: an interim data cut, reported last summer, looked better.